Maurizio Fava

MGH Depression Clinical and Research Program 
"Maurizio Fava"
Mean distance: 106866
Cross-listing: PsychTree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lamon-Fava S, So J, Mischoulon D, et al. (2020) Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 164: 102219
Choi KW, Jang EH, Kim AY, et al. (2020) Predictive inflammatory biomarkers for change in suicidal ideation in major depressive disorder and panic disorder: A 12-week follow-up study. Journal of Psychiatric Research. 133: 73-81
Park ER, Sylvia LG, Streck JM, et al. (2020) Launching a resiliency group program to assist frontline clinicians in meeting the challenges of the COVID-19 pandemic: Results of a hospital-based systems trial. General Hospital Psychiatry
Fava M, Mazzone E, Freeman M, et al. (2020) Double-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 32: e16-e24
Jha MK, Fava M, Minhajuddin A, et al. (2020) Association of anger attacks with suicidal ideation in adults with major depressive disorder: Findings from the EMBARC study. Depression and Anxiety
Sakurai H, Jain F, Foster S, et al. (2020) Long-term outcome in outpatients with depression treated with acute and maintenance intravenous ketamine: A retrospective chart review. Journal of Affective Disorders. 276: 660-666
Shelton RC, Fava M, Freeman MP, et al. (2020) Effect of adjunctive pimavanserin on suicidal ideation in patients with major depression: Analysis of the CLARITY study. Journal of Affective Disorders. 277: 478-485
Papakostas GI, Fava M, Freeman MP, et al. (2020) Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity study. International Clinical Psychopharmacology
Johe KK, Kay G, Kumar S, et al. (2020) NSI-189 phosphate, a novel neurogenic compound, selectively benefits moderately depressed patients: A post-hoc analysis of a phase 2 study of major depressive disorder. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 32: 182-196
Dichtel LE, Carpenter LL, Nyer M, et al. (2020) Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study. The American Journal of Psychiatry. appiajp202019080844
See more...